ArticleFrontiers in psychiatry2026
Impaired P50 sensory gating and depressive symptoms in adolescents with non-suicidal self-injury.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Non-suicidal self-injury (NSSI) in adolescents is highly prevalent and frequently co-occurs with depressive symptoms, yet the neurophysiological mechanisms underlying this comorbidity remain unclear. P50 sensory gating reflects early inhibitory control of redundant sensory input and has been implicated in affective disorders. This study examined whether P50 gating deficits are present in adolescents with NSSI and whether they are associated with depressive symptom severity and cognitive performance. Methods: Eighty-six adolescents with NSSI (55 with depressive symptoms; 31 without) and 50 healthy controls were recruited. Depressive symptoms were assessed using the 17-item Hamilton Depression Rating Scale (HAMD-17), and NSSI participants were stratified into depression (HAMD-17 ≥ 8) and non-depression (HAMD-17 < 8) subgroups. Cognitive function was evaluated using the MATRICS Consensus Cognitive Battery (MCCB). P50 sensory gating was measured using an auditory paired-click ERP paradigm, with gating indices calculated as the S2/S1 amplitude ratio and S1-S2 difference. Group differences in P50 indices were examined, and correlations and regression analyses were conducted to assess associations between P50 parameters, depressive symptoms, and cognition. Results: Significant group differences were observed in S2 amplitude and S2/S1 ratio both Conclusion: P50 sensory gating deficits in adolescent NSSI appear to be specifically associated with comorbid depressive symptoms rather than self-injurious behavior per se. S2-related inhibitory dysfunction may represent a neurophysiological marker of affective burden and selective executive vulnerability in this population.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.